More than 90% of RRMS patients given vidofludimus calcium in a clinical trial were free of confirmed disability worsening ...

The European Commission (EC) has approved argenx’s Vyvgart (efgartigimod alfa) subcutaneous (SC) injection to treat chronic ...

Enrollment is now complete in two Phase 3 clinical trials testing vidofludimus calcium in adults with relapsing forms of ...

Lapsing and relapsing addicts behave as they do because there has been a larger deterioration in their life. The decision to abuse a substance is simply the final step before they hit the bottom.

Studies have shown that primary progressive MS may take 2-3 years longer to diagnose than relapsing-remitting MS and people with PPMS are on average about 10 years older at diagnosis compared ...

Differentiating Between Progressive & Relapsing MS Given that disability progression is essential for a diagnosis of PPMS, physicians seek telltale signs that help them differentiate among the ...

Therapy in relapsing polychondritis is confined at the present time to the continuous use of corticosteroids. We have used prednisone, 30 mg. daily in divided doses, to control the acute disease.

In the relapsing-remitting multiple sclerosis (RRMS) setting, sessions included presentations on the revised 2024 McDonald criteria, disease-modifying treatments (DMTs) for MS, the diagnosis and ...

Relapsing Polychondritis Causes. Doctors don’t know what causes RP. Some think a certain gene may make you more likely to get it, but it doesn’t run in families.